Literature DB >> 12759718

Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.

Catherine Videau1, Ute Hochgeschwender, Hans Jürgen Kreienkamp, Miles B Brennan, Cécile Viollet, Dietmar Richter, Jacques Epelbaum.   

Abstract

Five somatostatin receptors (sst) have been cloned and mRNAs for the first four (sst1-4) are expressed in many brain regions. In the present work, we compared the distribution of the non-selective ligand [125I]-Tyr0-DTrp8-SRIF14 by autoradiography in 24 brain regions and pituitary in wild type, sst1- to sst4- or SRIF-gene invalidated (KO) mice. [125I]-Tyr0-DTrp8-SRIF14 binding was not significantly modified in sst1 KO mouse brain with the noticeable exception of the substantia nigra and only moderately decreased in pituitary. For sst2 KO mice, a general decrease (>75%) was observed in most regions, with the noticeable exception of the olfactory bulb and CA1 field of the hippocampus. SST3 KO brain displayed a decrease in binding in the external plexiform layer of the olfactory bulb only (-54%). For sst4 KO mice, [125I]-Tyr0-DTrp8-SRIF14 binding levels in the external plexiform (-35%) and glomerular (-39%) layers of the olfactory bulb as well as the hippocampus CA1 field (-68%) were significantly decreased. In SRIF KO mice, a significant increase in binding levels was observed in olfactory bulb, anterior olfactory nucleus, frontal cortex upper layers, lateral septum, CA1 field, zona incerta and lateral hypothalamus, substantia nigra, periaqueductal grey and parabrachial nucleus. Competition with selective ligands (CH275, octreotide or L-779,976, L-796,778, L-803,087, and octreotide or L-817,778, for sst1-5 receptors, respectively) was in accordance with these findings. Moreover, octreotide was still able to compete on residual [125I]-Tyr0-DTrp8-SRIF14 binding sites in sst2 KO pituitary. It is concluded that most [125I]-Tyr0-DTrp8-SRIF14 binding sites in mouse brain and pituitary belong to the sst2 subtype but for the olfactory bulb (sst3 and sst4 receptors), the CA1 of the hippocampus (sst4 receptors) and the pituitary (sst5 and sst1 receptors) in which other subtypes are also expressed. The overall increase in [125I]-Tyr0-DTrp8-SRIF14 binding in SRIF KO mice indicates that SRIF receptors, mostly from the sst2 subtype, are regulated by the endogenous ligand(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759718     DOI: 10.1007/s00210-003-0758-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

Review 1.  Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies.

Authors:  S Schulz; M Händel; M Schreff; H Schmidt; V Höllt
Journal:  J Physiol Paris       Date:  2000 May-Aug

2.  In vivo internalization of the somatostatin sst2A receptor in rat brain: evidence for translocation of cell-surface receptors into the endosomal recycling pathway.

Authors:  Z Csaba; V Bernard; L Helboe; M T Bluet-Pajot; B Bloch; J Epelbaum; P Dournaud
Journal:  Mol Cell Neurosci       Date:  2001-04       Impact factor: 4.314

3.  Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord.

Authors:  M Schindler; L A Sellers; P P Humphrey; P C Emson
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

4.  Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary.

Authors:  J C Reubi; R Maurer
Journal:  Neuroscience       Date:  1985-08       Impact factor: 3.590

5.  Expression of five somatostatin receptor mRNAs in the human brain and pituitary.

Authors:  V S Thoss; J Pérez; A Probst; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

6.  Classification and nomenclature of somatostatin receptors.

Authors:  D Hoyer; G I Bell; M Berelowitz; J Epelbaum; W Feniuk; P P Humphrey; A M O'Carroll; Y C Patel; A Schonbrunn; J E Taylor
Journal:  Trends Pharmacol Sci       Date:  1995-03       Impact factor: 14.819

7.  Development of a selective agonist at the somatostatin receptor subtype sstr1.

Authors:  G Liapakis; C Hoeger; J Rivier; T Reisine
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

8.  Somatostatin sst2 receptor knock-out mice: localisation of sst1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography.

Authors:  J P Hannon; C Petrucci; D Fehlmann; C Viollet; J Epelbaum; D Hoyer
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

Review 9.  Somatostatin receptors.

Authors:  K Raynor; T Reisine
Journal:  Crit Rev Neurobiol       Date:  1992

10.  Brain somatostatin receptors are up-regulated in somatostatin-deficient mice.

Authors:  José L Ramírez; Rania Mouchantaf; Ujendra Kumar; Veronica Otero Corchon; Marcelo Rubinstein; Malcolm J Low; Yogesh C Patel
Journal:  Mol Endocrinol       Date:  2002-08
View more
  13 in total

1.  Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies.

Authors:  François Gastambide; Cécile Viollet; Gabriel Lepousez; Jacques Epelbaum; Jean-Louis Guillou
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

Review 2.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

3.  Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

Authors:  A Stengel; M Goebel-Stengel; L Wang; M Larauche; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-06       Impact factor: 3.598

4.  Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia.

Authors:  Monica Beneyto; Harvey M Morris; Katherine C Rovensky; David A Lewis
Journal:  Neuropharmacology       Date:  2011-01-05       Impact factor: 5.250

5.  Somatostatin contributes to in vivo gamma oscillation modulation and odor discrimination in the olfactory bulb.

Authors:  Gabriel Lepousez; Aurélie Mouret; Catherine Loudes; Jacques Epelbaum; Cécile Viollet
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

6.  Identification of neuropeptide receptors expressed by melanin-concentrating hormone neurons.

Authors:  Gregory S Parks; Lien Wang; Zhiwei Wang; Olivier Civelli
Journal:  J Comp Neurol       Date:  2014-07-17       Impact factor: 3.215

7.  Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-27

8.  Effect of genetic SSTR4 ablation on inflammatory peptide and receptor expression in the non-inflamed and inflamed murine intestine.

Authors:  Joeri Van Op den Bosch; Pascal Torfs; Benedicte Y De Winter; Joris G De Man; Paul A Pelckmans; Eric Van Marck; David Grundy; Luc Van Nassauw; Jean-Pierre Timmermans
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

Review 9.  Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response.

Authors:  Andreas Stengel; Yvette F Taché
Journal:  Front Neurosci       Date:  2017-04-25       Impact factor: 4.677

10.  Circadian modulation of anxiety: a role for somatostatin in the amygdala.

Authors:  Anne Albrecht; Marlen Thiere; Jorge Ricardo Bergado-Acosta; Janine Poranzke; Bettina Müller; Oliver Stork
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.